Alexion is dedicated to world-class innovation, delivering therapies to patients with ultra-rare diseases. Find company and career information.
| Website | http://alxn.com/ |
| Revenue | $1.4 billion |
| Funding | $18 million |
| Employees | 12 (5 on RocketReach) |
| Phone | (475) 230-2596 |
| Fax | (203) 271-8198 |
| Technologies | |
| Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
| Keywords | Orphan Drugs, Biopharmaceutical, Innovative Therapies, Pharmaceutical Research, Drug Development, Biotechnology, Therapeutics, Pharmaceutical, Genetic Disorders, Clinical Trials, Healthcare, Protein Therapeutics, Immunology, Medical Research, Patient Care, Global Health, New Drug Applications |
| Competitors | Roche, Amgen, Novartis, AbbVie, Genentech, Sanofi, Biogen, GSK, Merck AH, Lilly India +43 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular ALEXION PHARMA ITALY SRL employee's phone or email?
The ALEXION PHARMA ITALY SRL annual revenue was $1.4 billion in 2026.
Federica Sottana is the Senior Director, Medical Affairs R and D of ALEXION PHARMA ITALY SRL.
5 people are employed at ALEXION PHARMA ITALY SRL.
The NAICS codes for ALEXION PHARMA ITALY SRL are [541, 32541, 3254, 54, 32, 325].
The SIC codes for ALEXION PHARMA ITALY SRL are [283, 28].